Sulpiride, but not haloperidol, up-regulates γ-hydroxybutyrate receptors in vivo and in cultured cells

European Journal of Pharmacology

Volumn 346, Issue 2-3, 1998, Pages 331-337

  Ratomponirina, Charline ^a   Gobaille, Serge ^a   Hodé, Yann ^a   Kemmel, V éronique ^a   Maitre, Michel ^a  

^a Center for Neurochemistry   (France)

Author keywords

Hydroxybutyrate receptor; Brain, rat; Chronic administration; Haloperidol; NCB 20 cells; Sulpiride

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; BRAIN RECEPTOR; HALOPERIDOL; SODIUM CHLORIDE; SULPIRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CELL CULTURE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ANIMALS; BRAIN CHEMISTRY; CELL LINE; CELLS, CULTURED; DOPAMINE ANTAGONISTS; HALOPERIDOL; INJECTIONS, INTRAVENTRICULAR; KINETICS; MALE; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; SODIUM OXYBATE; SULPIRIDE; UP-REGULATION;

EID: 0032502625     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00068-5     Document Type: Article

References (36)

1. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J. Pharmacol. Exp. Ther. 273:1995;1534-1543.
2. Benavides J., Rumigny J.F., Bourguignon J.J., Cash C., Wermuth C.G., Mandel P., Vincendon G., Maitre M. High affinity binding site for γ-hydroxybutyric acid in rat brain. Life Sci. 30:1982;953-961.
3. Chin M.Y., Kreutzer R.A., Dyer J.E. Acute poisoning from gamma-hydroxybutyrate in California. West. J. Med. 156:1992;380-384.
4. DeFeudis F.V., Collier B. Conversion of γ-hydroxybutyrate to γ-aminobutyrate by mouse brain in vivo. Experientia. 26:1970;1072-1073.
5. Della Pietra G., Illiano G., Capano V., Rava R. In vivo conversion of γ-hydroxybutyrate into γ-aminobutyrate. Nature. 210:1966;733-734.
6. Fadda F., Colombo G., Mosca E., Gessa G.L. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol. 24:1989;447-451.
7. Gallimberti L., Cibin M., Pagnin P., Sabbion R., Pani P.P., Pirastu R., Ferrara S.D., Gessa G.L. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:1993;77-81.
8. Gessa G.L., Vargiu L., Crabai F., Boero G.C., Caboni F., Camba R. Selective increase of brain dopamine induced by gamma hydroxybutyrate. Life Sci. 5:1966;1921-1930.
9. Harris N.C., Webb C., Greenfield S.A. The effects of gamma-hydroxybutyrate on the membrane properties of guinea pig pars compacta neurons in the substantia nigra in vitro. Neuroscience. 31:1989;363-370.
10. 3H]gamma-hydroxybutyrate binding sites as determined by quantitative autoradiography. J. Neurochem. 49:1987;1025-1032.
11. Hechler V., Gobaille S., Bourguignon J.J., Maitre M. Extracellular events induced by γ-hydroxybutyrate in striatum: a microdialysis study. J. Neurochem. 56:1991;938-944.
12. Hechler V., Gobaille S., Maitre M. Selective distribution pattern of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res. 572:1992;345-348.
13. Hechler V., Peter P., Gobaille S., Bourguignon J.J., Schmitt M., Ehrhardt J.D., Mark J., Maitre M. Gamma-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J. Pharmacol. Exp. Ther. 264:1993;1406-1414.
14. Hoes M.J., Vree T.B., Guelen P.J. Gamma-hydroxybutyric acid as hypnotic: clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. Encephale. 6:1980;93-99.
15. Kelly P.H., Moore K.E. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, γ-aminobutyric acid, γ-hydroxybutyric acid, apomorphine and amphetamine. Neuropharmacology. 17:1978;169-174.
16. Laborit H. Gamma-hydroxybutyrate, succinic semialdehyde and sleep. Prog. Neurobiol. 1:1973;257-274.
17. Lettieri J.T., Fung H.L. Dose-dependent pharmacokinetics and hypnotic effects of sodium γ-hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 208:1979;7-11.
18. Maitre M. The γ-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51:1997;337-361.
19. Maitre M., Cash C., Weissmann-Nanopoulos D., Mandel P. Depolarization-evoked release of γ-hydroxybutyrate from rat brain slices. J. Neurochem. 41:1983;287-290.
20. 3H]γ-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics. Eur. J. Pharmacol. 256:1994;211-214.
21. Mamelak M., Scharf M.B., Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate: a review of clinical and sleep laboratory findings. Sleep. 9:1986;285-289.
22. Minna J.D., Yavelow J. Expression of phenotypes in hybrid somatic cells derived from the nervous system. Genetics. 79:1975;373-383.
23. Nirenberg M., Wilson S., Higashida H., Rotter A., Krueger K., Busis N., Ray R., Kenimer J.G., Adler M. Modulation of synapse formation by cyclic adenosine monophosphate. Science. 222:1983;794-799.
24. Nirenberg M., Wilson S.P., Higashida H., Rotter A., Krueger K., Busis N., Ray R., Kenimer J., Adler M., Fukui M. Synapse formation by neuroblastoma hybrid cells. Cold Spring Harbor Symp. Quant. Biol. 68:1984;707-715.
25. Rating D., Hanefeld F., Siemes H., Kneer J., Jakobs C., Hermier M., Divry P. 4-Hydroxybutyric aciduria: a new inborn error of metabolism: I. Clinical review. J. Inherit. Metab. Dis. 7:1984;90-92.
26. Roth R.H., Doherty J.D., Walters J.R. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Res. 189:1980;556-560.
27. Shumate J.S., Snead O.C. Plasma and central nervous system kinetics of gamma-hydroxybutyrate. Res. Commun. Chem. Pathol. Pharmacol. 25:1979;241-256.
28. B binding sites: relation to the development of experimental absence seizures. Brain Res. 659:1994;147-156.
29. Snead O.C., Liu C.C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem. Pharmacol. 33:1984;2587-2590.
30. 2 receptors on cultured cells. J. Neurochem. 65:1995;569-577.
31. Vayer P., Maitre M. Regional differences in depolarization-induced release of γ-hydroxybutyrate from rat brain slices. Neurosci. Lett. 87:1988;99-103.
32. Vayer Ph., Maitre M. γ-Hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices. J. Neurochem. 52:1989;1382-1387.
33. Vayer P., Mandel P., Maitre M. Conversion of γ-hydroxybutyrate to γ-aminobutyrate in vitro. J. Neurochem. 45:1985;810-814.
34. Vayer P., Gobaille S., Mandel P., Maitre M. 3′-5′ Cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration: prevention by valproate and naloxone. Life Sci. 41:1987;605-610.
35. Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41:1987;1547-1557.
36. B receptors. Eur. J. Pharmacol. 212:1992;291-294.